SignalCorporate
BigHat Biosciences Announces $75 Million Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design
$75 million Series C financing advances AI-designed therapeutics and agentic protein design platform.
What changed
$75 million Series C financing advances AI-designed therapeutics and agentic protein design platform.
Why it matters
$75 million Series C financing advances AI-designed therapeutics and agentic protein design platform. — impact context not separately stored; see What changed.
← Dashboard
Sep 24, 2026 12:13 PM ET